Central Nervous System Parkinson Disease

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Parkinson Disease Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Parkinson Disease Projects
--axxonis Pharma AG.
--erly NeuroBiotec Pharma AG)
--Avicena Group Inc
--Cell Genesys Inc
--Britannia Pharmaceuticals Limited
--Chiesi Farmaceutici S.p.A
--Ceregene, Inc
--Genzyme Corporation
--Dainippon Sumitomo Pharma Co., Ltd.
--Newron Pharmaceuticals SpA
--Kyowa Hakko Kogyo Co., Ltd.
--Oxford BioMedica plc
--Otsuka Pharmaceutical Co., Ltd.
--Prestwick Pharmaceuticals, Inc.
--Oy Juvantia Pharma Ltd.
--Schwarz Pharma Ag
--Schering-Plough Corp
--Teva Pharmaceutical Industries Ltd
--Solvay S.A.
--Vernalis Plc ADR
--Vectura Group plc.

--Top Companies in early stage Parkinson Disease Projects
--Alseres Pharmaceuticals, Inc.
--Addex Pharmaceuticals SA
--AnGes MG, Inc.
--Amarin Corporation plc
--ExonHit Therapeutics SA
--Evotec AG
--Kyowa Hakko Kogyo Co., Ltd.
--Intra-Cellular Therapies, Inc.
--
--Merck & Co Inc
--Laboratorios Almirall, S.A.
--NeuroSearch A/S
--NeuroNova AB
--Penwest Pharmaceuticals Co
--Panacea Pharmaceuticals, Inc.
--Shionogi & Co., Ltd.
--Proneuron Biotechnologies, Inc.
--Sygnis Pharma AG
--Spherics, Inc
--Takeda Pharmaceutical Company Limited
--Synosia Therapeutics
--erly Synosis Therapeutics)

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View